종설 : 난치성 위식도역류질환의 원인 및 치료

논문상세정보
' 종설 : 난치성 위식도역류질환의 원인 및 치료' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • gastroesophageal reflux
  • heartburn
  • hypersensitivity
  • proton pump inhibitors
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
266 0

0.0%

' 종설 : 난치성 위식도역류질환의 원인 및 치료' 의 참고문헌

  • 위식도역류질환 임상진료지침 개정안 2012
    정혜경 대한소화기학회지 60 (4) : 195 ~ 218 [2012]
  • The acid pocket: a target for treatment in reflux disease?
    Kahrilas PJ Am J Gastroenterol 108 : 1058 ~ 1064 [2013]
  • Recent Advances in Noncardiac Chest Pain in Korea
    김정환 Gut and Liver 6 (1) : 1 ~ 9 [2012]
  • Proton pump inhibitors : better acid suppression when taken before a meal than without a meal
    Hatlebakk JG Aliment Pharmacol Ther 14 : 1267 ~ 1272 [2000]
  • Prevalence of asymptomatic erosive esophagitis and factors associated with symptom presentation of erosive esophagitis
    Lee D Scand J Gastroenterol 48 : 906 ~ 912 [2013]
  • Prevalence and risk factors for overlaps between gastroesophageal ref lux disease, dyspepsia, and irritable bowel syndrome: a population-based study
    Lee SY Digestion 79 : 196 ~ 201 [2009]
  • Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea
    Cho YS Am J Gastroenterol 100 : 747 ~ 753 [2005]
  • Predictive Factors of Response to Proton Pump Inhibitors in Korean Patients With Gastroesophageal Reflux Disease
    김성은 Journal of Neurogastroenterology and Motility (JNM) 21 (1) : 69 ~ 77 [2015]
  • Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end!
    Scarpignato C Neurogastroenterol Motil 24 : 697 ~ 704 [2012]
  • Genetic differences in CYP2C19single nucleotide polymorphisms among four Asian populations
    Yamada S J Gastroenterol 36 : 669 ~ 672 [2001]
  • Functional heartburn and non-erosive reflux disease
    Savarino V Dig Dis 25 : 172 ~ 174 [2007]
  • Effect of splitting the dose of esomeprazole on gastric acidity and nocturnal acid breakthrough
    Hammer J Aliment Pharmacol Ther 19 : 1105 ~ 1110 [2004]
  • Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group
    Lee KJ Digestion 79 : 131 ~ 136 [2009]
  • Comparison of acid inhibition with standard dosages of proton pump inhibitors in relation to CYP2C19 genotype in Japanese
    Sugimoto M Eur J Clin Pharmacol 70 : 1073 ~ 1078 [2014]
  • An Overview of Eosinophilic Esophagitis
    박효진 Gut and Liver 8 (6) : 590 ~ 597 [2014]
  • Achalasia in Korea: An Epidemiologic Study Using a National Healthcare Database
    김은경 Journal of Korean Medical Science 29 (4) : 576 ~ 580 [2014]